Hypertension
Hypertension. Definition: the force exerted by the blood against the walls of the bleed vessels. Adequate to maintain tissue perfusion during activity and rest ...
File link: http://www.mccc.edu/~martinl/documents/HTN.ppt
Hypertension
Hypertension. Definition: the force exerted by the blood against the walls of the bleed vessels. Adequate to maintain tissue perfusion during activity and rest ...
File link: http://www.mccc.edu/~martinl/documents/HTN.ppt
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramFarjad Ikram
Introduction to one of the most common symptoms that can represent a wide range of diseases, from benign to life-threatening, covering number of systems including gastrointestinal, cardiovascular, pulmonary, musculoskeletal and psychiatric.
Template design credits - http://www.slidescarnival.com
Hypertension is defined as persistently elevated arterial blood pressure (BP).
JNC7 Guidelines: Seventh Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure
JNC7 is the national clinical guideline that was developed to aid clinicians in the management of hypertension.
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramFarjad Ikram
Introduction to one of the most common symptoms that can represent a wide range of diseases, from benign to life-threatening, covering number of systems including gastrointestinal, cardiovascular, pulmonary, musculoskeletal and psychiatric.
Template design credits - http://www.slidescarnival.com
Hypertension is defined as persistently elevated arterial blood pressure (BP).
JNC7 Guidelines: Seventh Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure
JNC7 is the national clinical guideline that was developed to aid clinicians in the management of hypertension.
Educative power-point presentation for students in paediatrics, paediatric critical care, neonatology, And trainees or fellows in paediatric critical care
Educative power point presentation for trainees / post graduate students/ fellows in paediatrics/ paediatric cardiology/ paediatric critical care/ neonatology / emergency paediatrics
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
2. Asthma is associated with bothersome
symptoms and worsening QOL
Exacerbations – 67%
Substantial functional and emotional limitations
Acute asthma exacerbations poor asthma
control
Repeated measurement of lung function is
needed
T/t initiated after assessment of severity,
identification of risk factors and review of
therapy
3. Symptoms of breath shortness, cough,
wheezing
Progressive decrease in lung function
Common , chronic respiratory distress
EarlyT/t of exacerbations
Number of ED visits important for treatment
initiation.
4. Different pathogenesis of both acute and
chronic asthma
Increased neutrophil count seen in Broncho-
alveolar lavage fluid
Raised eosinophilia
Intense airway inflammation
IncreasedT cell markers in the peripheral
blood and increased numbers of Activated
CD25 to CD8 cells in the tissue.
5. Increased oxygen free radical production
Oxidation of lipids and proteins
Lipid per-oxidation cascade
Interleukin 13 and epidermal growth factor
receptor activation mucus cell hyperplasia
Increased levels of neutrophilic elastase, as
well as eosinophil degranulation with high
levels of eosinophil cationic protein
6. Previous H/o need of MechanicalVentilation
Hospital admission / ED visit for asthma care in
previous 1 year
On Inhaled corticosteriods
Recently discontinued gluco-corticoids
Use of > 1 canister/ month on inhaled short-
acting Beta 2 agonist
Need of 3 or more classes of asthma medication
Poor adherence to treatment
History of psychiatric illness or drug abuse
Lack of social support
Use of NSAIDs
Presence of Co-morbidities
8. Component Mild
exacerbatio
n
Moderate
exacerbatio
n
Severe
exacerbatio
n
Respiratory
failure
Normal
respiratory
rate
<2 months
<60/min
2 to 12 mths
<50 / min
1 to 5 years -
<40/min
6 to 8 years
- <30/min
Feeling of
dyspnoea
During rest
During
walking
---
+ when
increased
activity
+
Marked with
walking
Marked
Difficulty in
walking
Marked
Cannot walk
Daily life Speech
Feeding
Sleep
Pause after
one
sentence
Normal
Can sleep
Pause after
phrases
Slight
difficult
Occ wake up
Pause after
one word
Difficult
Disturbed
Impossible
Impossible
Disturbed
10. In child <5 years SCR, Cyanosis, Silent chest
Signs of exacerbation severity and vital signs
e.g. Level of consciousness,Temp, Pulse
rate, RR, BP, Use of accessory muscles,
Wheeze
Complicating factors E.g anaphylaxis,
pneumonia, pneumothorax
Signs of alternative conditions CCF, Upper
Airway Obstruction, Inhaled FB, Pulmonary
Embolism
11. Measurement of Lung Function
PEF or FEV in 1 second to be recorded without
delay before treatment initiation
PEF or FEV1 are useful valid measures of airway
calibre. Measurements of airway calibre
improves recognition of the degree of severity ,
the appropriateness or intensity of therapy and
decisions about Mx in hospital or at home
Lung function should be monitored until a clear
response toT/t has occurred or a plateau is
reached.
12. Oxygen saturation
To be monitored by Pulse-oximetry
When unable to perform PEF
SPO2 < 92% -> predictor of hospitalization
SPO2 < 90% -> signals need for Aggressive
therapy
13. For pt with a PEF or FEV1 <50% predicted
Respiratory failure if – PaO2 <60 mmHg,
PaCO2 > 45 mmHg
Respiratory acidosis on ABG
Presence of fatigue
Presence of lowered level of consciousness
15. Foreign body or Obstruction
Localized wheezing
H/o aspiration of FB
No improvement with broncho-dilators
Vocal cord dysfunction
Wheezing in neck region
Stress induced
Use of broncho-dilators increase anxiety
Frequent Inspiratory wheezing
16. Cardiac Dysfunction
CCF, Left ventricular dysfunction
Auscultatory crackles & rales
Pulmonary edema
Anaphylaxis
More stridor than wheezing
H/O exposure to allergen
17. Emphysema / COPD
Night time symptoms
CCAM
Early morning brassy Cough
Carcinoid Syndrome
Flushing, diarrhoea, or right sided heart
failure
Allergic Broncho-pulmonary Aspergillosis
Fever , haemoptysis, expectoration of brown
mucus plugs